Business Description
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd
ISIN : CNE1000000W4
Share Class Description:
FRA:FDY: Class HCompare
Compare
Traded in other countries / regions
688505.China01349.Hong KongFDY.Germany IPO Date
2020-11-02Description
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd is engaged in the research, development, manufacturing, and sale of biopharmaceutical products. Its product portfolio includes ALA (Aminolevulinic acid Hydrochloride); FuMeiDa and Libord. Geographically, it derives revenue from Mainland China.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 124.96 | |||||
| Equity-to-Asset | 0.84 | |||||
| Debt-to-EBITDA | 0.1 | |||||
| Interest Coverage | 47.13 | |||||
| Piotroski F-Score | N/A/9 | |||||
| Altman Z-Score | 9.23 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -3.4 | |||||
| 3-Year EBITDA Growth Rate | -15.6 | |||||
| 3-Year EPS without NRI Growth Rate | -5.2 | |||||
| 3-Year Book Growth Rate | 2.6 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 55.15 | |||||
| 9-Day RSI | 54 | |||||
| 14-Day RSI | 51.43 | |||||
| 6-1 Month Momentum % | -13.89 | |||||
| 12-1 Month Momentum % | -31.11 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.05 | |||||
| Quick Ratio | 3.94 | |||||
| Cash Ratio | 2.72 | |||||
| Days Inventory | 257.54 | |||||
| Days Sales Outstanding | 232.38 | |||||
| Days Payable | 45.34 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 3.83 | |||||
| Dividend Payout Ratio | 0.75 | |||||
| 3-Year Dividend Growth Rate | -2 | |||||
| Forward Dividend Yield % | 3.64 | |||||
| 5-Year Yield-on-Cost % | 6.54 | |||||
| Shareholder Yield % | 3.98 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 92.07 | |||||
| Operating Margin % | 13.39 | |||||
| Net Margin % | 12.65 | |||||
| FCF Margin % | -1.79 | |||||
| ROE % | 4.37 | |||||
| ROA % | 3.51 | |||||
| ROIC % | 9.52 | |||||
| ROC (Joel Greenblatt) % | 17.85 | |||||
| ROCE % | 4.19 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 19.28 | |||||
| PE Ratio without NRI | 20 | |||||
| Shiller PE Ratio | 11.73 | |||||
| Price-to-Owner-Earnings | 133.75 | |||||
| PS Ratio | 2.64 | |||||
| PB Ratio | 0.87 | |||||
| Price-to-Tangible-Book | 0.91 | |||||
| Price-to-Operating-Cash-Flow | 46.52 | |||||
| EV-to-EBIT | 49 | |||||
| EV-to-EBITDA | 49 | |||||
| EV-to-Revenue | 6 | |||||
| EV-to-FCF | -346.55 | |||||
| Price-to-Projected-FCF | 1.37 | |||||
| Price-to-Graham-Number | 0.91 | |||||
| Price-to-Net-Current-Asset-Value | 1.54 | |||||
| Price-to-Net-Cash | 2.73 | |||||
| Earnings Yield (Greenblatt) % | 2.04 | |||||
| FCF Yield % | -0.23 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 103.974 | ||
| EPS (TTM) (€) | 0.014 | ||
| Beta | -0.16 | ||
| Volatility % | 20.2 | ||
| 14-Day RSI | 51.43 | ||
| 14-Day ATR (€) | 0.003366 | ||
| 20-Day SMA (€) | 0.2412 | ||
| 12-1 Month Momentum % | -31.11 | ||
| 52-Week Range (€) | 0.234 - 0.356 | ||
| Shares Outstanding (Mil) | 1,043 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Frequently Asked Questions
What is Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd(FRA:FDY)'s stock price today?
The current price of FRA:FDY is €0.25. The 52 week high of FRA:FDY is €0.36 and 52 week low is €0.23.
When is next earnings date of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd(FRA:FDY)?
The next earnings date of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd(FRA:FDY) is .
Does Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd(FRA:FDY) pay dividends? If so, how much?
The Dividend Yield %  of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd(FRA:FDY) is 3.83% (As of Today), Highest Dividend Payout Ratio of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd(FRA:FDY) was 0.75. The lowest was 0.21. And the median was 0.39. The  Forward Dividend Yield % of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd(FRA:FDY) is 3.64%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers